Answers are grounded in this paper and cite their sources.
Within the context of 3 years of PSEI for subclinical lymphedema, variables of ALND, taxane-based chemotherapy, RNI, body mass index >30, and rurality increased risk.
No takes yet. Share an insight, caveat, or question.
Koelmeyer et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: